If you regularly recycle your plastics, papers and glass, you know they can be re-used for new purposes. You might be unaware, however, that smart research scientists can also recycle drugs, re-purposing them to treat other diseases.
In a partnership with the University of Kansas and the National Institutes of Health, LLS is testing auranofin, an arthritis drug, to treat patients with relapsed chronic lymphocytic leukemia. The collaboration is part of an aggressive effort to get new treatments to patients faster. Because the drug in this project was already FDA approved, scientists were able to move from animal studies to a Phase I trial for blood cancer patients in just one year! Helen Anbinder beat her CLL into remission twice thanks to a treatment developed by an LLS-funded researcher who her family supported. When her leukemia recurred a few years later, another new medication was waiting in the wings. Helen again credited LLS. "Research was progressing so quickly that I was able to be treated with a new drug combination that wasn't even available two years earlier." Researcher collaborations, novel combinations and new uses for existing drugs all give hope to people like Helen. And forward-thinking people like you who invest in research give hope to all cancer patients. If you haven't made a donation, please consider one, not someday, but today. Gratefully, John E. WalterPresident & CEO PS. We would like to honor every patient living with a blood cancer with a donation. Please donate in honor of one now.
Aaron Jones was 7 when he was diagnosed with leukemia. He battled valiantly for three years but tragically lost his life to the disease on June 28, 2012.
During his cancer journey Aaron spent many of his days at Children’s Hospital in Pittsburgh. While there, he had the thrill of meeting several of his heroes from the Pittsburgh Steelers, including Troy Polamalu and Brett Keisel. Aaron got so sick so quickly that he never got the chance to attend a Steelers game, but in August the Steelers organization and The Leukemia & Lymphoma Society teamed up to invite his family – mom, dad and two brothers - to attend a game.
“It has been hard since we lost Aaron; Our house is so empty without his laughs,” his mother, Shelly Jackson said. “Thank you for remembering the families, too, whether they are still in treatment or cured or passed on to heaven. It meant a lot to us but I think I was the only one who cried at the Steeler game that night.”
Thank you for your generous support through GlobalGiving.
This is a story of a woman's cancer journey and the appreciation she has for The Leukemia & Lymphoma Society (LLS).
In February of 2010, I received the frightening news that I had Hodgkin's disease. After a PET scan and two biopsies, I was hit with the additional news that I was positive for stage 2 Lymphoma. I was 42 and scared to death. When I went in for my first visit with oncologist Dr. Rafique of Tri County Hematology and Oncology in Ohio, I found out how expensive chemotherapy is and how health insurance doesn't cover it all. Fortunately, my doctor directed me to LLS and they helped with more than 50% of my insurance co-pages. This was a major relief and allowed me to concentrate on fighting the illness and getting better. My 12 rounds of chemotherapy ended in the fall of 2010. Unfortunately, I sustained lung damage from one of the chemotherapy agents and had to spend three weeks in the hospital recovering. I had another PET scan in April of 2011 and was given the great news that I was in remission! I am forever grateful for my wonderful doctor and the financial support I received from LLS. I encourage everyone to help this great organization and other cancer patients to take advantage of the support they provide. ~ Cynthia Clark Cynthia was so grateful for the help she received during treatment, she has designated LLS as a beneficiary in her retirement plan. Cynthia has insured that the hope and support she felt from LLS during her treatment will carry-on for others. On behalf of patients everywhere, thank you Cynthia. Learn more about how you can designate LLS as a beneficiary. Wishing you the best of health.